INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

71,123 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
RB
Ream James BDirector
GATXGATX CORP
Grant or award
A$31K
169 sh
Nov 2, 2026Nov 4, 2026
Page 113 of 1779
← PrevNext →
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

9
SR
Shrewsbury RondaDirector
SRCE1ST SOURCE CORP
Grant or award
A$16K
181 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
MA
Merriman Dwight ADirector
MDBMongoDB, Inc.
Open-market sale · 10b5-1 plan
SELL$278K
800 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SD
Spector DavidDirector, Chairman & CEO
PFSIPennyMac Financial Services, Inc.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
HE
Halverson EmilyVP Finance, Controller & Treas
ALKALASKA AIR GROUP, INC.
Option exercise
M—
970 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$530K
2,121 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
FC
Freedman ConstanceDirector
ELSEQUITY LIFESTYLE PROPERTIES INC
Grant or award
A$3,722
76 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
DE
Davis Robert EmersonDirector
HTZHERTZ GLOBAL HOLDINGS, INC
Grant or award
A—
58.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
CS
Chittipeddi SaileshDirector
LTRXLANTRONIX INC
Option exercise
M—
8,541 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
CV
Coloma Jason VDirector, Chief Executive Officer
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$166K
5,345 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SB
Stiefel Justin BDirector, CEO & Treasurer
IPSTIP STRATEGY HOLDINGS, INC.
Tax withholding
F$138
62 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
MT
Moskoff Gregory TMD,Controller and CAO
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
1,355 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
KS
Keane Robert SDirector
ATROASTRONICS CORP
Derivative conversion
C—
173.8K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
MJ
Mccarvel Thomas JDirector
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
1,232 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,830 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$254K
1,049 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$268K
1,080 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
AR
Amdahl Rachel RSVP-Chief Operations Officer
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
482 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SL
Sing George LDirector
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
7,439 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
LJ
Larosa Joseph JEVP General Counsel and Secret
REGNREGENERON PHARMACEUTICALS, INC.
Option exercise
M—
12.3K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
AE
Allison Richard E JrDirector
KMBKIMBERLY CLARK CORP
Grant or award
A—
300 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
PC
Pussinen CynthiaDirector, Chief Executive Officer
ESLAEstrella Immunopharma, Inc.
Grant or award
A—
1.00M sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
GD
Graham Tracy DDirector
SRCE1ST SOURCE CORP
Grant or award
A$14K
158 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
HE
Halverson EmilyVP Finance, Controller & Treas
ALKALASKA AIR GROUP, INC.
Tax withholding
F$9,075
237 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
6,995 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
ML
Mewhorter Bryce LSVP & Corporate Controller
ECLECOLAB INC.
Option exercise
M—
2,948 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SA
Swartz AllisonEVP, GC
PGNYProgyny, Inc.
Grant or award
A—
11.4K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$406K
1,671 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
JJ
Johnson Peter JosephDirector
EBMTEagle Bancorp Montana, Inc.
Grant or award
A—
1,232 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$318K
1,275 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
LM
Latimer Timothy MichaelDirector, Chief Executive Officer
FRVOFervo Energy Co
Disposition to issuer
D—
10.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
TK
Turner KamiChief Accounting Officer
DFINDonnelley Financial Solutions, Inc.
Option exercise
M—
4,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
PM
Peabody MarkExecutive VP & Pres-Aerospace
ATROASTRONICS CORP
Option exercise
M$48K
1,831 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
WJ
Warren JoshuaEVP, Chief Financial Officer
FDSFACTSET RESEARCH SYSTEMS INC
Grant or award
A—
9,376 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SB
Stiefel Justin BDirector, CEO & Treasurer
IPSTIP STRATEGY HOLDINGS, INC.
Option exercise
M—
1,458 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
LE
Larsen Nils ErikDirector
HTZHERTZ GLOBAL HOLDINGS, INC
Grant or award
A—
58.6K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
SF
Schurz Todd F.Director
SRCE1ST SOURCE CORP
Grant or award
A$14K
158 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

9
HG
Howarth Alex G.Director
ALTAltimmune, Inc.
Grant or award
A—
160.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
DM
Davidson MattDirector, President and CEO
AZRAzora Therapeutics, Inc. (DE)
Derivative conversion
C—
101 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

9
VJ
Vassil JonathanChief Revenue Officer
TOSTToast, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
1,951 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence